Active Ingredient History
Meprednisone, also known as NSC-63278 and Betapar, is a glucocorticoid receptor agonist.It has anti-inflammatory and immunosuppressive activity. It was approved since 1978, but its marketing in USA was discontinied since. Meprednisone is marketed in Argentina under trade name Copytren for treatment of rheumatic diseases, diseases of collagen, dermatological, gastrointestinal, respiratory and ophtalmological diseases. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Collagen Diseases (approved 1978)
Gastrointestinal Diseases (approved 1978)
Respiration Disorders (approved 1978)
Rheumatic Diseases (approved 1978)
Skin Diseases (approved 1978)
Abiraterone Acetate (Phase 3)
Abortion, Habitual (Phase 3)
Abortion, Spontaneous (Phase 2)
Acanthamoeba Keratitis (Phase 2)
Adrenal Hyperplasia, Congenital (Phase 4)
Adrenal Insufficiency (Phase 3)
Alveolitis, Extrinsic Allergic (Phase 4)
Androgens (Phase 3)
Anemia, Aplastic (Phase 3)
Anosmia (Phase 1/Phase 2)
Antineoplastic Agents (Phase 3)
Antineoplastic Agents, Hormonal (Phase 3)
Arthralgia (Phase 2)
Arthritis (Phase 2)
Arthritis, Psoriatic (Phase 3)
Arthritis, Rheumatoid (Phase 4)
Aspergillosis, Allergic Bronchopulmonary (Phase 3)
Asthma (Phase 4)
Atherosclerosis (Phase 1/Phase 2)
Bell Palsy (Phase 4)
Bites and Stings (Phase 3)
Breast Neoplasms (Phase 3)
Canavan Disease (Phase 1/Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cardiomyopathies (Phase 2/Phase 3)
Cataract (Phase 4)
Churg-Strauss Syndrome (Phase 3)
Cognition Disorders (Phase 2)
Colitis (Phase 3)
Colitis, Ulcerative (Phase 2/Phase 3)
Collagen (Phase 4)
Colorectal Neoplasms (Phase 2)
Conjunctivitis (Phase 2)
Conjunctivitis, Allergic (Phase 2)
Corneal Diseases (Phase 4)
Corneal Edema (Phase 4)
Coronavirus Infections (Phase 3)
COVID-19 (Phase 3)
Crohn Disease (Phase 2/Phase 3)
Cyclin-Dependent Kinase 4 (Phase 3)
Cyclin-Dependent Kinase 6 (Phase 3)
Cytochrome P-450 Enzyme System (Phase 3)
Deficiency Diseases (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Retinopathy (Phase 4)
DNA Repair-Deficiency Disorders (Phase 2)
Down Syndrome (Phase 3)
Drugs, Investigational (Phase 1/Phase 2)
Drug Therapy (Phase 2)
Dry Eye Syndromes (Phase 4)
Edema (Phase 4)
Endodontics (Phase 2)
Enzyme Inhibitors (Phase 3)
Esophageal Stenosis (Phase 4)
Exercise (Phase 3)
Eye Diseases, Hereditary (Phase 4)
Facial Nerve Diseases (Phase 4)
Facial Paralysis (Phase 4)
Fasting (Phase 4)
Fertilization in Vitro (Phase 2)
General Surgery (Phase 4)
Giant Cell Arteritis (Phase 2)
Glaucoma (Phase 4)
Glaucoma, Open-Angle (Phase 3)
Glomerulonephritis, IGA (Phase 3)
Gout (Phase 4)
Graft vs Host Disease (Phase 3)
Graves Disease (Phase 3)
Healthy Volunteers (Phase 1)
Hearing Loss, Sensorineural (Phase 2)
Hematologic Neoplasms (Phase 2)
Hemodynamics (Phase 2)
Hemorrhage (Phase 3)
Hepatic Encephalopathy (Phase 2)
Hepatitis, Alcoholic (Early Phase 1)
Herpes Labialis (Phase 4)
Hodgkin Disease (Phase 3)
Hormones (Phase 3)
Hyperthyroidism (Phase 3)
Hypophosphatasia (Phase 4)
Immune System Diseases (Phase 2)
Immunoglobulin G4-Related Disease (Phase 2)
Infections (Phase 3)
Infertility (Phase 2/Phase 3)
Inflammation (Phase 4)
Intestinal Diseases (Phase 3)
Intraocular Pressure (Phase 4)
Ischemic Stroke (Phase 4)
Keratoconus (Phase 4)
Keratoplasty, Penetrating (Phase 4)
Kidney Diseases (Phase 3)
Language Disorders (Phase 3)
Leber Congenital Amaurosis (Phase 1/Phase 2)
Leflunomide (Phase 1/Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, T-Cell (Phase 1)
Lichen Planus (Phase 2/Phase 3)
Liver Diseases (Phase 2)
Liver Failure, Acute (Phase 2)
Lung Diseases (Phase 1/Phase 2)
Lupus Nephritis (Phase 4)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 4)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Macular Degeneration (Phase 4)
Macular Edema (Phase 4)
Medulloblastoma (Phase 2)
Melanoma (Phase 2)
Membranes (Phase 2)
Microvascular Angina (Phase 3)
Mucocutaneous Lymph Node Syndrome (Phase 3)
Mucopolysaccharidoses (Phase 4)
Mucopolysaccharidosis II (Phase 4)
Multiple Sclerosis (Phase 3)
Muscular Diseases (Phase 4)
Muscular Dystrophy, Duchenne (Phase 4)
Mutation (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 2)
Myocarditis (Phase 2/Phase 3)
Myocardium (Phase 2)
Nasal Polyps (Phase 4)
Neoadjuvant Therapy (Phase 2)
Neointima (Phase 2)
Neonatology (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 2)
Nephrosis, Lipoid (Phase 4)
Nephrotic Syndrome (Phase 4)
Neuroblastoma (Phase 2)
Obstetric Labor, Premature (Phase 3)
Ocular Hypertension (Phase 3)
Oncogenes (Phase 2)
Optic Neuropathy, Ischemic (Phase 2)
Orbital Pseudotumor (Phase 3)
Otitis Media with Effusion (Phase 4)
Pain (Phase 4)
Pain, Postoperative (Phase 4)
Paralysis (Phase 3)
Patient Preference (Phase 4)
Pemphigoid, Benign Mucous Membrane (Phase 2/Phase 3)
Pemphigoid, Bullous (Phase 4)
Physiological Effects of Drugs (Phase 3)
Pneumonia (Phase 4)
Polymyalgia Rheumatica (Phase 3)
Prednisolone (Phase 3)
Prednisone (Phase 3)
Pregnancy, Ectopic (Phase 1/Phase 2)
Premature Birth (Phase 3)
Prostatic Neoplasms (Phase 3)
Psoriasis (Phase 4)
Psychotic Disorders (Phase 2)
Pterygium (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Pulpitis (Phase 4)
Purpura, Thrombotic Thrombocytopenic (Phase 2/Phase 3)
Refractive Surgical Procedures (Phase 4)
Remission Induction (Phase 3)
Renal Dialysis (Phase 2)
Retinal Detachment (Phase 4)
Retinal Diseases (Phase 4)
Retinal Vein Occlusion (Phase 4)
Retroperitoneal Fibrosis (Phase 4)
Rhinitis, Allergic (Phase 3)
Sarcoidosis (Phase 4)
Sarcoidosis, Pulmonary (Phase 4)
Sarcoma (Phase 3)
Schizophrenia (Phase 2)
Scleroderma, Systemic (Phase 2)
Sinusitis (Phase 4)
Spasms, Infantile (Phase 2/Phase 3)
Steroid Synthesis Inhibitors (Phase 3)
Stroke (Phase 3)
Substance Withdrawal Syndrome (Phase 3)
Takayasu Arteritis (Phase 3)
Testicular Neoplasms (Phase 3)
Thrombocytopenia (Phase 4)
Thyroid Gland (Phase 2)
Treatment Outcome (Phase 4)
Triple Negative Breast Neoplasms (Phase 3)
Urogenital Neoplasms (Phase 3)
Uveitis (Phase 4)
Vascular Remodeling (Phase 3)
Ventricular Dysfunction, Left (Phase 3)
Ventricular Remodeling (Phase 3)
Virus Diseases (Phase 4)
Vision, Ocular (Phase 4)
Vitreoretinal Surgery (Phase 4)
Wet Macular Degeneration (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue